Results with allo-SCT in patients with relapsed/refractory HL treated with anti-PD-1, a multicenter retrospective cohort study: subcommittee of transplantation and cellular therapy (GATMO-TC) of the Argentinian Hematology Society (SAH)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Results with allo-SCT in patients with relapsed/refractory HL treated with anti-PD-1, a multicenter retrospective cohort study: subcommittee of transplantation and cellular therapy (GATMO-TC) of the Argentinian Hematology Society (SAH)

Published:2022-09-16 Issue:14 Volume:63 Page:3508-3510
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Warley Fernando¹^ORCID,Berro Mariano²,Palmer Silvina³,Castro Martin⁴,Ferini Gonzalo¹,Lopez Orozco Milagros⁵,Otero Victoria¹,Arbelbide Jorge¹,Foncuberta Cecilia⁶,Yantorno Sebastián⁷,Basquiera Ana⁷^ORCID

Affiliation:

1. Hospital Italiano de Buenos Aires, Buenos Aires, Argentina

2. Hospital Austral, Buenos Aires, Argentina

3. Hospital Británico de Buenos Aires, Buenos Aires, Argentina

4. Sanatorio Anchorena, Buenos Aires, Argentina

5. Hospital Privado de Córdoba, Córdoba, Argentina

6. Instituto Alexander Fleming, Buenos Aires, Argentina

7. Hospital Privado Centro Medico de Cordoba, Cordoba, Argentina

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2022.2123238

Reference12 articles.

1. Hodgkin lymphoma: A review and update on recent progress

2. The Impact of Underreported Veterans Affairs Data on National Cancer Statistics: Analysis Using Population-Based SEER Registries

3. Safety and Efficacy of Anti-PD-1 Monoclonal Antibodies in Patients With Relapsed or Refractory Lymphoma: A Meta-Analysis of Prospective Clinic Trails

4. Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience

5. Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of transplantation in Hodgkin lymphoma;Frontiers in Oncology;2023-01-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3